Alba Lucia Combita

6PUBLICATIONS
23CO-AUTHORS
Gene and molecular therapyMolecular targetsPredictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)Adolescent health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 30, 2025
Correction: Mejía-García et al. Development and Validation of an Extracellular Matrix Gene Expression Signature for Prognostic Prediction in Patients with Uveal Melanoma. Int. J. Mol. Sci. 2025, 26, 4317.

Alejandro Mejía-García, Carlos A Orozco, Julius Herzog

|Oct 14, 2025
Molecular determinants of neoadjuvant chemotherapy resistance in breast cancer: An analysis of gene expression and tumor microenvironment.

Hedda Michelle Guevara-Nieto, Carlos A Orozco-Castaño, Rafael Parra-Medina

|May 14, 2025
Development and Validation of an Extracellular Matrix Gene Expression Signature for Prognostic Prediction in Patients with Uveal Melanoma.

Alejandro Mejía-García, Carlos A Orozco, Julius Herzog

|Mar 28, 2025
Current Applications of Single-Cell RNA Sequencing in Glioblastoma: A Scoping Review.

Edgar G Ordóñez-Rubiano, Nicolás Rincón-Arias, William J Shelton

|Nov 04, 2022
Metabolic pathways enriched according to ERG status are associated with biochemical recurrence in Hispanic/Latino patients with prostate cancer.

Natalia L Acosta-Vega, Rodolfo Varela, Jorge Andrés Mesa

|Oct 06, 2021
Reduction in Vaccine HPV Type Infections in a Young Women Group (18-25 Years) Five Years after HPV Vaccine Introduction in Colombia.

Alba L Combita, Viviana Reyes, Devi Puerto

Pageof 1

Frequent Collaborators

2 joint publications

Yina Zambrano

2 joint publications

Diego A Bonilla

2 joint publications

Johanna González

2 joint publications

Seth Frietze